25 Live Stock Analysis Videos 04-04-2018 Tickers

New Post Public Reply Private Reply Replies (0) Message Board
Chasing Stars
276
25 Live Stock Analysis Videos 04-04-2018

Tickers Covered Today:
$ANDI $CELZ $DIRV $DSGT $FRFS $FUSZ $GNIN $GRWC $GSFD $HAON $IGNE $IMTV $INTK $LIBE $LIGA $MEDH $MJTV $NECA $NIHD $PHIL $PLPL $POTN $SFOR $SMCE $TRCH

(Text Transcripts Below)

Please Note: We do NOT get paid for these videos from ANYONE. We do NOT trade stocks and do NOT own any of the stocks we covered below. These videos are 100% UNBIASED. The stocks we cover come from YOU the investors. So if you have a stock you would like to see us cover reply to this post or any of the videos we post. We will be sure to add them to our next set of videos.

Thanks to all of you who help get these videos out there! We truly appreciate it!


ANDI Andiamo Corp. https://youtu.be/umhPLXFUqoY
CELZ Creative Medical Technology Holdings Inc. https://youtu.be/slu38C04JnA
DIRV DirectView Holdings Inc. https://youtu.be/Ff3lCKYjEXY
DSGT DSG Global Inc https://youtu.be/sdaGptcYbuQ
FRFS Firefish Inc. https://youtu.be/54ulEE3vWBI
FUSZ nFusz Inc. https://youtu.be/enTLhzvEbX4
GNIN Green Innovations Ltd. https://youtu.be/2TwPOYM15oo
GRWC Grow Condos Inc. https://youtu.be/RhexV4VKpV8
GSFD Global Seafood Technologies Inc. https://youtu.be/eIi_ZnpiYAo
HAON Halitron Inc. https://youtu.be/o4HPHKqizlU
IGNE IGENE Biotechnology Inc. https://youtu.be/YhJicr7mT1U
IMTV Imagination TV Inc. https://youtu.be/38MeukTKv1w
INTK Industrial Nanotech Inc. https://youtu.be/IoXloXlqONQ
LIBE Liberated Energy Inc. https://youtu.be/rarzQZfRzcg
LIGA LIG Assets Inc. https://youtu.be/clTV5YIlkmw
MEDH MedX Holdings Inc. https://youtu.be/W00W5QcAVzQ
MJTV Michael James Enterprises Inc. https://youtu.be/KqYK9mXddIA
NECA New America Energy Corp. https://youtu.be/EfGbB7xBVT8
NIHD NII Holdings Inc. https://youtu.be/4wxhUlz6_QU
PHIL PHI Group Inc. https://youtu.be/1b3dBwpY-ts
PLPL Plandai Biotechnology Inc. https://youtu.be/a2ATiqTD6ug
POTN Potnetwork Holdings Inc. https://youtu.be/FoEVted1cDM
SFOR Strikeforce Technologies Inc. https://youtu.be/lA2u1CFD3l8
SMCE SMC Entertainment Inc. https://youtu.be/EU8JspmCQ-c
TRCH Torchlight Energy Resources Inc. https://youtu.be/E0qqjrjmRN0
Source of production: https://investorshangout.com/live


ANDI - .0058 Res .0060/70/80/90/01 Support .0050 must hold. Would need to break 0.165 for a reversal.
CELZ - .0073 Res .0080/90/01/0120 Support .0060/50 Chart looks to be setting up with a bounce.
DIRV - .0195 Res .0250/.03/.0350 Support .0188/.0150 Watch for a possible bounce here .0188.
DSGT - .0075 Res .0080 Support .0070/60/50/40 Could begin to pull back here some. Watch for the .0070 area to hold.
FRFS - .10 Res .11/.13 Support .09/.08 A break of .11 could breakout.
FUSZ - .7726 Res 1.00/1.20/1.35 Support .8135/.65 A break of 1.35 would be a bullish reversal.
GNIN - .0290 Res .03/.0350/.04 Support .0250/.02/.0150 Watch for a bounce here off of the .0250 imo.
GRWC - .0390 Res .04/.05 Support .0350/.03 must hold. Watch for a possible bounce here back into the lower bb.
GSFD - .0175 Res .02/.0250/.03/.0350 Support .0172/.0150 must hold. A break of .02 with vol would indicate a move much higher imo
HAON - .0002 Res .0002/4/6/8 Support .0001 Watch for the break of .0004 to confirm. Check the SS.
IGNE - .0005 Res .0006/8/10/12 Support .0004/2 A break of .0008 would be bullish. Chart setting up?
IMTV - .0003 Res .0005 Support .0002. Watch for a .0006 hit to confirm a possible move here. Setting up?
INTK - .0032 Res .0033/35/40 Support .0030/28/25 A break of .0035 would be bullish imo.
LIBE - .0099 Res .01/.0125/.0150 Support .0090 must hold. A break of .0150 would be a bullish reversal imo.
LIGA - .0139 Res .0140 Support .0130/.0120/.0110 A break of .0140 could breakout again.
MEDH - .0670 Res .07/.08 Support .06/.05 Watch for a bounce here off of the .06
MJTV - .0095 Res .01/.0150/.02 Support .0080/.0060 Watch for the break of .01. Could breakout. Chart setting up?
NECA - .0003 Res .0004/6/8/10 Support .0002 Watch for a close above .0004 to confirm a move here imo.
NIHD - 2.26 Res 2.28 Support 2.10/2.00/1.90/1.75/1.60 Chart looks to be setup again. Watch for the 2.28 break here.
PHIL - .0330 Res .0330/.0369/.0394/.0421 Support .03 must hold. A break of .0421 could be a reversal.
PLPL - .0158 Res .0170/0180/02 Support .0150/0140/0120/01 A break of .02 could breakout. .01 must hold.
POTN - .3530 Res .3717/.4043 Support .33/.30 A break of .4043 would be bullish. .30 must hold.
SFOR - .0125 Res .0128/.0140/.0150/.0160 Support .0120/.0110/.01 Watch for a bullish break of .0128.
SMCE - .0055 Res .0060/85/01/0122 Support .0040 must hold. A break of .0122 could breakout.
TRCH - 1.32 Res 1.35 Support 1.30/1.27/1.25 Could be setting up. Watch for the 1.35 break.



DISCLAIMER

Myself nor any admins at InvestorsHangout.com Trade Stocks.
This video is for informational purposes only!

ALWAYS do your own research before
buying any stock! Don’t buy a stock just
because someone said so!

I have NOT Been Compensated For This Video!
DISCLAIMER

I am the Owner/Admin of Investors Hangout and do not trades stocks!

Just doing what I do best, music and coding. I like Honeypots.
1755928657_bd4ed327189c2a56695beb91cd534570.gif
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading